Viewing Study NCT01226732


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-05-22 @ 3:03 PM
Study NCT ID: NCT01226732
Status: COMPLETED
Last Update Posted: 2022-03-08
First Post: 2010-10-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Sponsor: SCRI Development Innovations, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic or Unresectable Solid Tumor Malignancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid tumor View
None Capecitabine View
None Hsp90 inhibitor AUY922 View